MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
199 hedge funds and large institutions have $3.17B invested in Momenta Pharmaceuticals, Inc. in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 79 increasing their positions, 53 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
36% more capital invested
Capital invested by funds: $2.33B → $3.17B (+$840M)
17% more funds holding
Funds holding: 170 → 199 (+29)
Holders
199
Holding in Top 10
3
Calls
$20.6M
Puts
$1.11M
Top Buyers
| 1 | +$59.1M | |
| 2 | +$57.7M | |
| 3 | +$52.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$29.5M |
| 5 |
BlackRock
New York
|
+$25.4M |
Top Sellers
| 1 | -$80.7M | |
| 2 | -$64.2M | |
| 3 | -$51.9M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$49.3M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$34M |